Wavelength pharmaceuticals | Radio Compass News | PharmaCompass.com

Grow Your Pharma Business Digitally

X

Market Place

Sourcing support

Sourcing Support

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

All News Wavelength Pharmaceuticals

Pierre Luzeau on Seqens U.S. R&D Lab Investment

02 Jun 2023 //

CONTRACT PHARMA

SK Capital Partners completes acquisition of SEQENS and merges Wavelength Pharma

17 Dec 2021 //

PRESS RELEASE

SK Capital Partners to acquire SEQENS and merge Wavelength Pharma

26 Aug 2021 //

PRESS RELEASE

Wavelength Pharmaceuticals signs collaboration agreement with Tikun olam-Cannbit

16 Aug 2021 //

PRESS RELEASE

Biocatalysis: An Indispensable Tool for API Synthesis

07 Jun 2021 //

PRESS RELEASE

Israeli API maker Wavelength buys up majority stake in Indian firm making drug

19 Feb 2021 //

ENDPTS

Wavelength Pharmaceuticals Further Strengthens Its Global Supply Chain with Acquisition of Vanamali Organics

18 Feb 2021 //

PRESS RELEASE

Wavelength Further Strengthens Its Global Supply Chain Acquisition of Vanamali

17 Feb 2021 //

BUSINESSWIRE

HPAPI Complexity Prompts New Delivery Mechanisms

03 Dec 2020 //

PHARMTECH

Production Scale Up to Meet COVID-19 Demand

09 Sep 2020 //

CONTRACT PHARMA

Ensuring a Safe and Robust Supply of Pharma Materials

03 Aug 2020 //

PHARMTECH

Wavelength Pharmaceuticals Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19 Patients

20 Apr 2020 //

PRESS RELEASE

Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19

20 Apr 2020 //

BIOSPACE

Wavelength Ups API Production for Essential Respiratory Meds

20 Apr 2020 //

CONTRACTPHARMA

Wavelength’s Cetirizine Dihydrochloride confirmed to be free of nitrosamine

19 Apr 2020 //

PRESS RELEASE

Wavelength’s Cilostazol confirmed to be free of nitrosamine impurities

18 Apr 2020 //

PRESS RELEASE

Wavelength Pharma Resolves a Major Supply Crisis for a Leading API Manufacturer

17 Apr 2020 //

PRESS RELEASE

Wavelength Resolves a Majo CASE STUDY Supply Crisis for a Leading API Mfg

17 Apr 2020 //

PRESS RELEASE

Wavelength Pharmaceuticals Resolves a Major Supply Crisis for a Leading API MFG

17 Apr 2020 //

PRESS RELEASE

Wavelength Resolves a Major CASE STUDY Supply Crisis for a API Manufacturer

04 Apr 2020 //

PRESS RELEASE

Wavelength will be exhibiting at Contract Pharma’s 2020 Conference

12 Mar 2020 //

PRESS RELEASE

Wavelength will be exhibiting at Contract Pharma’s 2020 Contracting

05 Feb 2020 //

PRESS RELEASE

Wavelength Pharmaceuticals Obtained on March 28th 2019 CEP For Fulvestrant

15 Apr 2019 //

PRESS RELEASE

Wavelength Pharmaceuticals Obtained on March 28th 2019 CEP For Fulvestrant

12 Mar 2019 //

PRESS RELEASE

Wavelength Pharmaceuticals completes cGMP drug process inspection audit of Neot

04 Feb 2019 //

PRESS RELEASE

Wavelength successfully completes USFDA audit at its Neot Hovav Mfg site

12 Jul 2018 //

PRESS RELEASE

Wavelength completes cGMP drug process inspection audit of Neot Hovav site

12 Mar 2018 //

PRESS RELEASE

Israeli Pharma Company Wavelength Appoints New CEO

30 Nov 2017 //

CALCALISTECH

Wavelength `S Names Iftach Seri as Chief Executive Officer and Tami Cohen as CFO

17 Nov 2017 //

BUSINESSWIRE

SK Capital will pay $110m for Perrigo`s drug ingredients business

15 Aug 2017 //

IN PHARMATECHNOLOGIST

Perrigo selling its ingredient business to investor for $110M

11 Aug 2017 //

FIERCE PHARMA

SK Capital To Buy Perrigo`s Active Pharma Ingredients Business

10 Aug 2017 //

NASDAQ